Literature DB >> 1347078

Latent equid herpesviruses 1 and 4: detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues.

H M Welch1, C G Bridges, A M Lyon, L Griffiths, N Edington.   

Abstract

The polymerase chain reaction (PCR) and co-cultivation were used to identify the lymphoreticular system as the site of latency of equid herpesvirus I (EHV-1). Primers for PCR were designed from aligned nucleotide sequences of the glycoprotein gB genes to amplify the same region of both the EHV-1 and EHV-4 genomes. Subsequent restriction digests using specific enzymes distinguished the amplified fragments of the EHV-1 genome from those of the EHV-4 genome. Ten weeks following an experimental infection of five ponies with EHV-1, latent virus was detected by PCR and recovered by co-cultivation, predominantly from lymphoid tissues draining the respiratory tract. Significantly, latent EHV-1 also persisted in peripheral blood leukocytes (PBL). Latent EHV-4, presumably from a preceding natural infection, was also detected in some tissues, including PBL, from all animals. Of additional interest was the recovery of EHV-1 and -4 only in the presence of the ubiquitous EHV-2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347078     DOI: 10.1099/0022-1317-73-2-261

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  The equine herpesvirus 2 E1 open reading frame encodes a functional chemokine receptor.

Authors:  G Camarda; G Spinetti; G Bernardini; C Mair; N Davis-Poynter; M C Capogrossi; M Napolitano
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Potential of equine herpesvirus 1 as a vector for immunization.

Authors:  Sascha Trapp; Jens von Einem; Helga Hofmann; Josef Köstler; Jens Wild; Ralf Wagner; Martin Beer; Nikolaus Osterrieder
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Pathogenesis and clinical signs of equine herpesvirus-1 in experimentally infected ponies in vivo.

Authors:  G A Sutton; L Viel; P S Carman; B L Boag
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

4.  Detection of latency-associated transcripts of equid herpesvirus 1 in equine leukocytes but not in trigeminal ganglia.

Authors:  P M Chesters; R Allsop; A Purewal; N Edington
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Expression and function of the equine herpesvirus 1 virion-associated host shutoff homolog.

Authors:  X Feng; Y G Thompson; J B Lewis; G B Caughman
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

6.  Impact of ETIF deletion on safety and immunogenicity of equine herpesvirus type 1-vectored vaccines.

Authors:  Helga Hofmann-Sieber; Jens Wild; Nicole Fiedler; Karsten Tischer; Jens von Einem; Nikolaus Osterrieder; Heike Hofmann; Josef Köstler; Ralf Wagner
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

7.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Andrea Carvelli; Romain Paillot; Alessandro Broglia; Lisa Kohnle; Francesca Baldinelli; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-12

8.  Equine gammaherpesvirus 2 (EHV2) is latent in B lymphocytes.

Authors:  H E Drummer; G H Reubel; M J Studdert
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  A type-specific serological test to distinguish antibodies to equine herpesviruses 4 and 1.

Authors:  B S Crabb; C M MacPherson; G H Reubel; G F Browning; M J Studdert; H E Drummer
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

10.  In situ study on the pathogenesis and immune reaction of equine herpesvirus type 1 (EHV-1) infections in mice.

Authors:  T Bartels; F Steinbach; G Hahn; H Ludwig; K Borchers
Journal:  Immunology       Date:  1998-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.